2020 /CNW/ -- Clarivate Analytics Plc (NYSE:CCC) a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that Cortellis Clinical Trials ...

2020 /CNW/ -- Clarivate Analytics Plc (NYSE:CCC) a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that Cortellis Clinical Trials ...

LONDON and PHILADELPHIA, April 20, 2020 /PRNewswire/ -- Clarivate ... insights and analytics to accelerate the pace of innovation, today announced that Cortellis Clinical Trials Intelligence ...

LONDON and PHILADELPHIA, April 20, 2020 /CNW/ -- Clarivate Analytics Plc (NYSE:CCC) a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced ...

Clinical trial planning platform enables researchers to pinpoint best sites to support trial protocols and patient recruitment needs LONDON and PHILADELPHIA, April 20, 2020 /PRNewswire ...

Clinical trial ... best sites to support trial protocols and patient recruitment needs LONDON and PHILADELPHIA, April 20, 2020 /PRNewswire/ -- Clarivate Analytics Plc (NYSE:CCC) a global leader ...

1, 2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE ... to develop eight active substances for entry into Phase I clinical trials in order to bring just one to market. In addition, the cost ...

Justin Hubbard, Vice President, Product Management, Life Sciences and Healthcare at Clarivate ... clinical and pharmacovigilance adverse event data, visualizations and preclinical safety analytics.